Specifically, in gastric cancer, miR‐33a‐5p directly targets the 3′UTR of SLC7A11‐AS1 and SLC7A11, resulting in a notable decrease in the expression of both SLC7A11‐AS1 and SLC7A11.39 Here, SLC7A11 is linked to gastric cancer.